Network-strucured" model for Irish Biobank:
This article was originally published in Clinica
Plans to establish the Irish Biobank entered a new phase last week, with the first public meeting on the project. Its defining features will be its centrally-managed structure, involving a network of local biobank centres with a "single point of access and methods for research", a spokesperson for the Royal College of Physicians of Ireland (RCPI) told Clinica. The meeting (Dublin, December 3) was hosted by the RCPI and Biobank Ireland, a group of experts convened by the health ministry to develop the project, to raise awareness of its potential in helping to improve cancer care. The speakers included Professor Geraldine Thomas, director of the Wales Cancer Bank, on which the Irish project is being modelled.
You may also be interested in...
Sangamo licensed Biogen zinc finger protein transcription factor candidates in an alliance worth over $2bn. Exercising an option it gained in 2017, Takeda bought celiac disease-focused PvP Biologics for up to $330m in earn-outs. A strong showing of IPOs prompted biopharma financing to increase from last month.
With many non-CE marked products being allowed onto various EU member state markets, who is going to monitor compliance? TÜV-SÜD’s Bassil Akra calls for cooperation to avoid unsafe products being used on patients.
Indian drug makers appear confident of meeting both domestic and global requirements for hydroxychloroquine sulphate after India relaxed export curbs on the product, subject to strict monitoring, against the backdrop of requests from global heads of government for supplies of the potential treatment for COVID-19.